Head & Neck Cancer

From the death of civil rights icon John Lewis to a woman pretending to have cancer as part of a larger donation scam, here’s what’s making the headlines in the cancer space this week.

A laryngectomy choir offers rehabilitation and inspiration to patients after throat cancer.

The Food and Drug Administration (FDA) has granted accelerated approval to expand the indication of Gardasil 9 (Human papillomavirus 9-valent vaccine, recombinant), a vaccine for the prevention of HPV, to prevent oropharyngeal and other head and neck cancers caused by certain HPV types.

Voice actor Rob Paulsen opens up about how a lump on his neck led to a stage 3 diagnosis.

Dealing with cancer can be a stressful enough experience without having to navigate a worldwide pandemic, as many are doing due to COVID-19. But according to Rob Paulsen, voice actor and throat cancer survivor, the key to making it through each day may be in finding a reason to smile.

This week on the CURE Talks Cancer podcast, we spoke with voice actor Rob Paulsen, who was diagnosed with stage 3 metastatic squamous cell carcinoma in 2016, about how his experience helped him find a reason to smile, even when times get tough.

Patients with head and neck paragangliomas, a rare neuroendocrine tumor type, may be safely and effectively treated with proton therapy.

Marijuana is often linked to fighting cancer and its effects, but in the case of head and neck squamous cell carcinoma, researchers found that it may increase the progression of the disease.

Mona P is finding hope, life and healing after carcinoma of the pharynx.

Fast track designation has been granted for the investigational therapy tipifarnib to treat patients with HRAS mutant head and neck squamous cell carcinomas.

Patients with head and neck cancer who received acupuncture during therapy saw lower incidence and severity of dry mouth compared with those who received oral health education.

The investigational agent tipifarnib shows promise in patients with head and neck cancer who have a certain gene mutation.

In this episode of the “CURE Talks Cancer” podcast, we spoke with Jason Mendelsohn, a stage 4 HPV-related throat cancer survivor who created a web site geared to raising awareness about HPV-related cancers.

Poison’s Rikki Rockett discusses the immunotherapy clinical trial that led him into remission.

In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with a caregiver about support for others taking care of a loved one with cancer through a letter she wrote to her younger self.

The Food and Drug Administration has approved Keytruda for recurrent locally advanced or metastatic squamous cell carcinoma of the esophagus in certain patients.

From Beth Chapman’s untimely passing to cancer fundraising via esports, here’s what is making headlines in the cancer space this week.

The Food and Drug Administration approved Keytruda monotherapy and in combination with chemotherapy for the front-line treatments of patients with metastatic or unresectable recurrent head and neck squamous cell carcinoma.

From today’s top entertainers to racial disparities in access to pain treatment, here’s what is making headlines in the cancer space this week.

Patients with head and neck cancer may soon have more effective, less toxic choices as immunotherapy moves into first-line treatment and novel targeted drugs are explored.

Compared with the general population, men and women with type 2 diabetes face greater risk of developing certain cancers, such as colorectal, kidney, liver and more.

This essay was written by Maria Campos nominating Mary Kernan, RN, OCN, of Smilow Cancer Center At Yale New Haven Health, New Haven, Connecticut, for CURE®'s Extraordinary Healer® Award.

Here are the top 5 CURE stories for April 2019.

Use of two medicated mouthwashes reduced pain from oral mucositis during the first four hours after administration; however, the results were not deemed clinically different when compared with placebo.